Sapir Alex bought FULC
February 2, 2026 · Form 4 insider transaction
Sapir Alex bought 650,000 shares of Fulcrum Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
650,000
Price
$0.00
Total value
N/A
InsiderSapir Alex
RoleOfficer, Director
SecurityStock option - Right to Buy
Transaction codeA: Grant or award
Transaction dateFebruary 2, 2026
Filing dateFebruary 4, 2026
Shares owned after650,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option was granted on February 2, 2026 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2026, subject to the reporting person's continued service on each such vesting date.